Key filing fact
MAK Capital Fund LP disclosed 13% ownership in Autolus Therapeutics plc Ordinary Shares, nominal value $0.000042 per share, and American Depositary Shares ("ADS"). Each ADS represents one Ordinary Share (AUTL) on 31 Mar 2026.
Key facts
- MAK Capital Fund LP filed SCHEDULE 13G/A for Autolus Therapeutics plc Ordinary Shares, nominal value $0.000042 per share, and American Depositary Shares ("ADS"). Each ADS represents one Ordinary Share (AUTL).
- Disclosed ownership: 13%.
- Date of event: 31 Mar 2026.
Change
- Previous schedule filing date: 13 Feb 2026.
- Current filing was accepted on 15 May 2026, 15:04.
Research use
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Evidence
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original Filing